EO rescheduling seen as buying opportunity for cannabis stocks, says ATB Capital

Cannabis stocks surged nearly 91% ahead of the Schedule 3 Executive Order but fell 29% in a “sell the news” correction, largely due to profit-taking and misconceptions about immediate rescheduling, ATB Capital tells investors in a research note. The pullback is viewed as an overreaction, creating a buying opportunity, with rescheduling potentially effective in 1H26 and substantial upside, the firm says.